PortfoliosLab logo
RVNC vs. BIPC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RVNC and BIPC is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

RVNC vs. BIPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revance Therapeutics, Inc. (RVNC) and Brookfield Infrastructure Corporation (BIPC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

RVNC:

$381.02M

BIPC:

$4.71B

EPS

RVNC:

-$3.34

BIPC:

-$2.07

PS Ratio

RVNC:

1.48

BIPC:

1.28

PB Ratio

RVNC:

12.30

BIPC:

37.49

Total Revenue (TTM)

RVNC:

$125.27M

BIPC:

$3.69B

Gross Profit (TTM)

RVNC:

$88.57M

BIPC:

$2.30B

EBITDA (TTM)

RVNC:

-$58.99M

BIPC:

$3.62B

Returns By Period


RVNC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

BIPC

YTD

1.08%

1M

8.30%

6M

-9.91%

1Y

19.65%

3Y*

-1.78%

5Y*

10.66%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Revance Therapeutics, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

RVNC vs. BIPC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVNC
The Risk-Adjusted Performance Rank of RVNC is 4141
Overall Rank
The Sharpe Ratio Rank of RVNC is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of RVNC is 5050
Sortino Ratio Rank
The Omega Ratio Rank of RVNC is 5151
Omega Ratio Rank
The Calmar Ratio Rank of RVNC is 3131
Calmar Ratio Rank
The Martin Ratio Rank of RVNC is 3535
Martin Ratio Rank

BIPC
The Risk-Adjusted Performance Rank of BIPC is 7070
Overall Rank
The Sharpe Ratio Rank of BIPC is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of BIPC is 6565
Sortino Ratio Rank
The Omega Ratio Rank of BIPC is 6363
Omega Ratio Rank
The Calmar Ratio Rank of BIPC is 7474
Calmar Ratio Rank
The Martin Ratio Rank of BIPC is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RVNC vs. BIPC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Revance Therapeutics, Inc. (RVNC) and Brookfield Infrastructure Corporation (BIPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

RVNC vs. BIPC - Dividend Comparison

RVNC has not paid dividends to shareholders, while BIPC's dividend yield for the trailing twelve months is around 4.22%.


TTM20242023202220212020
RVNC
Revance Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
BIPC
Brookfield Infrastructure Corporation
4.22%4.05%4.34%3.70%4.11%2.01%

Drawdowns

RVNC vs. BIPC - Drawdown Comparison


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

RVNC vs. BIPC - Volatility Comparison


Loading data...

Financials

RVNC vs. BIPC - Financials Comparison

This section allows you to compare key financial metrics between Revance Therapeutics, Inc. and Brookfield Infrastructure Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20212022202320242025
59.88M
929.00M
(RVNC) Total Revenue
(BIPC) Total Revenue
Values in USD except per share items